The General Pharmaceutical Factory of Harbin Pharmaceutical Group is a key production base of antibiotics and the nation’s first class pharmaceutical company. It is a backbone company for both Harbin Pharmaceutical Group and local economy. Annual sales are approximately 3 billion Chinese Yuan now with an export of 30 million US dollars. In the past 40 years, Harbin Pharma has stuck to the concept of “best quality for human health” and the company spirit of “Unity, practicality, innovation and superiority” and abided by the management philosophy of “superior quality and service”. The company has grown very fast by deepening reform, encourage innovation, changing management concepts and improving management systems. Now the company owns total assets of 1.6 billion Chinese Yuan and has a workforce of more than 8000 employees, in which 2000 employees are technicians. The company maintains more than 30 workshops, which are all GMP compliant. The company also has a first run quality control center, a drug research institute and two back up power plants with a capacity of 16700 KW.

The company mainly produces penicillin, cephalosporin and cardiovascular drugs and APIs. The fermentation capacity is above 3000 cubic meters. The company produces 3 billion injection vials, 1 billion tablets and 4 billion capsules and is capable of producing 3 antibiotic cores: 6-APA, 7-ACA, 7-ADCA. The company is a number one producer of cefazolin sodium, cefotaxime sodium, and cefazolin sodium vials. Key products penicillin, cephalosporin, powder vials capsules, tablets are all GMP compliant. Penicillin G was approved by FDA and sold to more than 20 countries.